Skip to content

Drug interactions

Dexamethasone-tobramycin + Ocrelizumab

Severity: Minor

Dexamethasone-tobramycin and Ocrelizumab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ocrelizumab depletes B cells, and systemic corticosteroids add immunosuppression that may raise infection risk. Topical dexamethasone-tobramycin delivers little systemic steroid, so the added risk is small.

What this interaction means in plain words

Dexamethasone-tobramycin and Ocrelizumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dexamethasone-tobramycin belongs to Anti Bacterial; Ocrelizumab belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression from B-cell depletion and corticosteroid effects, relevant mainly with systemic steroid exposure.

What to do

No change is needed for topical use. With systemic dexamethasone, monitor for infection signs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexamethasone-tobramycin and Ocrelizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dexamethasone-tobramycin with Ocrelizumab?

MediHelp rates the interaction as minor. Dexamethasone-tobramycin and Ocrelizumab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ocrelizumab depletes B cells, and systemic corticosteroids add immunosuppression that may raise infection risk. Topical dexamethasone-tobramycin delivers little systemic steroid, so the added risk is small.

How serious is the interaction between Dexamethasone-tobramycin and Ocrelizumab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No change is needed for topical use. With systemic dexamethasone, monitor for infection signs.

What other medicines interact with Dexamethasone-tobramycin?

MediHelp also lists interactions of Dexamethasone-tobramycin with, for example, Capreomycin, Carboplatin, Ciprofloxacin. The full list is on the Dexamethasone-tobramycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in